<!DOCTYPE html><html><head><meta charSet="utf-8" class="next-head"/><title class="next-head">ALiEM Cards</title><meta name="viewport" content="initial-scale=1.0, width=device-width" class="next-head"/><meta charset="utf-8" class="next-head"/><meta http-equiv="x-ua-compatible" content="ie=edge" class="next-head"/><link rel="apple-touch-icon" sizes="180x180" href="/static/Favicons/apple-touch-icon.png" class="next-head"/><link rel="icon" type="image/png" href="/static/Favicons/favicon-32x32.png" sizes="32x32" class="next-head"/><link rel="icon" type="image/png" href="/static/Favicons/favicon-16x16.png" sizes="16x16" class="next-head"/><link rel="mask-icon" href="/static/Favicons/safari-pinned-tab.svg" color="#00b092" class="next-head"/><link rel="shortcut icon" href="/static/Favicons/favicon.ico" class="next-head"/><link rel="stylesheet" href="https://fonts.googleapis.com/css?family=Open+Sans" class="next-head"/><link rel="preload" href="/_next/static/1~ee3OFOv6kXxZUoU_eCb/pages/card.js" as="script"/><link rel="preload" href="/_next/static/1~ee3OFOv6kXxZUoU_eCb/pages/_app.js" as="script"/><link rel="preload" href="/_next/static/1~ee3OFOv6kXxZUoU_eCb/pages/_error.js" as="script"/><link rel="preload" href="/_next/static/runtime/webpack-89179faa512dd01fbb62.js" as="script"/><link rel="preload" href="/_next/static/chunks/commons.ce4c8f8c27f9b1d9e256.js" as="script"/><link rel="preload" href="/_next/static/chunks/styles.9b76ae77785496d5351a.js" as="script"/><link rel="preload" href="/_next/static/runtime/main-cfdfd101abde4b1d3f2a.js" as="script"/><link rel="stylesheet" href="/_next/static/css/commons.b3e9c004.chunk.css"/><link rel="stylesheet" href="/_next/static/css/styles.0fc85b66.chunk.css"/></head><body><div id="__next"><div data-reactroot=""><div><div class="header" role="banner"><div class="header__logo"><a href="/"><img src="/static/logo.svg"/></a></div><div class="header__nav-button"><button class="hamburger hamburger__squeeze"><span class="hamburger__box"><span class="hamburger__inner"></span></span></button></div><nav class="header__nav header__nav--closed" role="navigation"><ul><li><a href="/cards/">Cards</a></li><li><a href="/categories/">Categories</a></li><li><a href="/about/">About</a></li></ul></nav></div><div class="search"><div class="search__input" role="search"><input type="text" placeholder="Search" aria-label="Search for cards" value=""/></div></div></div><main class="content container" role="main"><article role="article"><h1>2013 AHA Guidelines: Contraindications for Thrombolytics</h1><div class="card"><div class="card__meta"><div><strong>Author: </strong>Michelle Lin, MD</div><div><strong>Updated:</strong> <!-- -->9/10/2010</div></div><div class="card__content"><h1 id="stroke-2013-aha-guidelines-on-contraindications-for-thrombolytics">Stroke: 2013 AHA Guidelines on Contraindications for Thrombolytics</h1>
<h2 id="inclusion-criteria">Inclusion Criteria</h2>
<ol>
<li>Diagnosis of ischemic stroke causing measurable neurologic deficit</li>
<li>Age &ge;18 years</li>
</ol>
<h2 id="exclusion-criteria">Exclusion Criteria</h2>
<h3 id="0-3-hours-from-symptom-onset">0-3 hours from symptom onset</h3>
<h4 id="absolute-exclusion-criteria">Absolute Exclusion Criteria</h4>
<ul>
<li>Significant head trauma or prior stroke in previous 3 months</li>
<li>Symptoms suggest subarachnoid hemorrhage</li>
<li>Arterial puncture at noncompressible site in previous 7 days</li>
<li>History of previous intracranial hemorrhage</li>
<li>Intracranial neoplasm, AV malformation, or aneurysm</li>
<li>Recent intracranial or intraspinal surgery</li>
<li>Elevated BP (SBP &gt;185 mmHg or DBP &gt;110 mmHg)</li>
<li>Active internal bleeding</li>
<li>Acute bleeding diathesis (Platelet count &lt;100,000/mm3; Heparin received within 48 hours, resulting in aPTT above upper limit of normal)</li>
<li>Current use of anticoagulant with INR &gt;1.7 or PT &gt; 15 sec     </li>
<li>Current use of direct thrombin inhibitors or direct factor Xa inhibitors with elevated sensitive lab tests (such as aPTT, INR, platelet, and ecarin clotting time; TT; or appropriate factor Xa activity assays)</li>
<li>Blood glucose &lt;50 mg/dL (2.7 mmol/L)</li>
<li>CT shows multilobar infarct (hypodensity &gt;1/3 cerebral hemisphere)</li>
</ul>
<h4 id="relative-exclusion-criteria">Relative Exclusion Criteria</h4>
<ul>
<li>Only minor or rapidly improvement stroke symptoms (clearing spontaneously)</li>
<li>Pregnancy</li>
<li>Seizure at onset with postictal residual neurologic impairments</li>
<li>Major surgery or serious trauma within previous 14 days</li>
<li>Recent GI or urinary tract hemorrhage within previous 21 days</li>
<li>Recent acute MI within previous 3 months</li>
</ul>
<h3 id="3-4-5-hours-from-symptom-onset">3-4.5 hours from symptom onset</h3>
<h4 id="absolute-exclusion-criteria">Absolute Exclusion Criteria</h4>
<blockquote>
<p><strong><em>List is same as for 0-3 hour time frame above PLUS any of the following</em></strong>:</p>
</blockquote>
<ul>
<li>Age &gt;80 years</li>
<li>Severe stroke (NIHSS &gt;25)</li>
<li>Taking oral anticoagulant regardless of INR</li>
<li>History of both diabetes mellitus AND prior ischemic stroke</li>
</ul>
<h2 id="references">References</h2>
<ul>
<li>Jauch EC, Saver JL, Adams HP Jr, Bruno A, Connors JJ, Demaerschalk BM, Khatri P, McMullan PW Jr, Qureshi AI, Rosenfield K, Scott PA, Summers DR, Wang DZ, Wintermark M, Yonas H; American Heart Association Stroke Council; Council on Cardiovascular Nursing; Council on Peripheral Vascular Disease; Council on Clinical Cardiology. Guidelines for the early management of patients with acute ischemic stroke: a guideline for healthcare professionals from the American Heart Association/American Stroke Association. Stroke. 2013 Mar;44(3):870-947. PMID: 23370205. [<a href="http://stroke.ahajournals.org/content/44/3/870.full.pdf">Source</a>]</li>
<li>NINDS rt-PA Stroke Study Group. Tissue plasminogen activator for acute ischemic stroke. N Engl J Med. 1995 Dec 14;333(24):1581-7. [<a href="http://www.nejm.org/doi/full/10.1056/NEJM199512143332401">Source</a>]</li>
</ul>
</div></div></article></main><div class="footer" role="contentinfo"><div class="container"><div class="row footer__cc"><div class="footer__cc-image"><a rel="license" href="http://creativecommons.org/licenses/by-nc-nd/3.0/"><img alt="creative-commons" src="/static/by-nc-nd.svg"/></a></div><div class="footer__cc-text">This work is licensed under a<!-- --> <a rel="license" href="http://creativecommons.org/licenses/by-nc-nd/3.0/">Creative Commons Attribution-NonCommercial-NoDerivs 3.0 Unported License</a>.</div></div><div class="row footer__links"><div><a href="/contact/">Contact</a></div><div><a href="/contact/">Get Involved</a></div><div><a href="/about/">About</a></div></div><div class="row row--centered"><div class="container footer__disclaimer">ALiEM Cards content is intended for use by healthcare professionals. Users of this site should exercise their own clinical judgment as to the reliability and accuracy of its information. Non-healthcare-professionals who use this site do so at their own risk. Content on this site should not be construed as medical advice. Users should always confer with medical profoessionals regarding decisions about medications, evaluations and other medical treatments.</div></div></div></div></div></div><script>__NEXT_DATA__ = {"props":{"pageProps":{"card":{"slug":"tpa-contraindications","title":"2013 AHA Guidelines: Contraindications for Thrombolytics","authors":["Michelle Lin, MD"],"categories":[{"slug":"neurology","name":"Neurology"}],"created":"2010/09/10","updated":"2013/05/13","body":"\n# Stroke: 2013 AHA Guidelines on Contraindications for Thrombolytics\n\n## Inclusion Criteria\n\n1. Diagnosis of ischemic stroke causing measurable neurologic deficit\n2. Age \u0026ge;18 years\n\n## Exclusion Criteria\n\n### 0-3 hours from symptom onset\n\n#### Absolute Exclusion Criteria\n\n- Significant head trauma or prior stroke in previous 3 months\n- Symptoms suggest subarachnoid hemorrhage\n- Arterial puncture at noncompressible site in previous 7 days\n- History of previous intracranial hemorrhage\n- Intracranial neoplasm, AV malformation, or aneurysm\n- Recent intracranial or intraspinal surgery\n- Elevated BP (SBP \u003e185 mmHg or DBP \u003e110 mmHg)\n- Active internal bleeding\n- Acute bleeding diathesis (Platelet count \u0026lt;100,000/mm3; Heparin received within 48 hours, resulting in aPTT above upper limit of normal)\n- Current use of anticoagulant with INR \u003e1.7 or PT \u003e 15 sec     \n- Current use of direct thrombin inhibitors or direct factor Xa inhibitors with elevated sensitive lab tests (such as aPTT, INR, platelet, and ecarin clotting time; TT; or appropriate factor Xa activity assays)\n- Blood glucose \u0026lt;50 mg/dL (2.7 mmol/L)\n- CT shows multilobar infarct (hypodensity \u003e1/3 cerebral hemisphere)\n\n#### Relative Exclusion Criteria\n\n- Only minor or rapidly improvement stroke symptoms (clearing spontaneously)\n- Pregnancy\n- Seizure at onset with postictal residual neurologic impairments\n- Major surgery or serious trauma within previous 14 days\n- Recent GI or urinary tract hemorrhage within previous 21 days\n- Recent acute MI within previous 3 months\n\n### 3-4.5 hours from symptom onset\n\n#### Absolute Exclusion Criteria\n\n\u003e **_List is same as for 0-3 hour time frame above PLUS any of the following_**:\n\n- Age \u003e80 years\n- Severe stroke (NIHSS \u003e25)\n- Taking oral anticoagulant regardless of INR\n- History of both diabetes mellitus AND prior ischemic stroke\n\n## References\n\n- Jauch EC, Saver JL, Adams HP Jr, Bruno A, Connors JJ, Demaerschalk BM, Khatri P, McMullan PW Jr, Qureshi AI, Rosenfield K, Scott PA, Summers DR, Wang DZ, Wintermark M, Yonas H; American Heart Association Stroke Council; Council on Cardiovascular Nursing; Council on Peripheral Vascular Disease; Council on Clinical Cardiology. Guidelines for the early management of patients with acute ischemic stroke: a guideline for healthcare professionals from the American Heart Association/American Stroke Association. Stroke. 2013 Mar;44(3):870-947. PMID: 23370205. [[Source](http://stroke.ahajournals.org/content/44/3/870.full.pdf)]\n- NINDS rt-PA Stroke Study Group. Tissue plasminogen activator for acute ischemic stroke. N Engl J Med. 1995 Dec 14;333(24):1581-7. [[Source](http://www.nejm.org/doi/full/10.1056/NEJM199512143332401)]\n"}}},"page":"/card","pathname":"/card","query":{"slug":"tpa-contraindications"},"buildId":"1~ee3OFOv6kXxZUoU_eCb","nextExport":true};__NEXT_LOADED_PAGES__=[];__NEXT_REGISTER_PAGE=function(r,f){__NEXT_LOADED_PAGES__.push([r, f])}</script><script async="" id="__NEXT_PAGE__/card" src="/_next/static/1~ee3OFOv6kXxZUoU_eCb/pages/card.js"></script><script async="" id="__NEXT_PAGE__/_app" src="/_next/static/1~ee3OFOv6kXxZUoU_eCb/pages/_app.js"></script><script async="" id="__NEXT_PAGE__/_error" src="/_next/static/1~ee3OFOv6kXxZUoU_eCb/pages/_error.js"></script><script src="/_next/static/runtime/webpack-89179faa512dd01fbb62.js" async=""></script><script src="/_next/static/chunks/commons.ce4c8f8c27f9b1d9e256.js" async=""></script><script src="/_next/static/chunks/styles.9b76ae77785496d5351a.js" async=""></script><script src="/_next/static/runtime/main-cfdfd101abde4b1d3f2a.js" async=""></script></body></html>